Characterisation of kinin receptors on the human isolated umbilical artery

被引:9
作者
Abbas, F
Clayton, JK
Marshall, KM [1 ]
Senior, J
机构
[1] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England
[2] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England
基金
英国惠康基金;
关键词
D O I
10.1677/joe.0.1560389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the kinin responses on human umbilical artery (HUA) and to characterise the kinin receptors present on this tissue. The HUA was found to constrict in response to both the B-2 receptor agonist, bradykinin (BK), and the B-1 receptor agonist, des-Arg(9)-BK. The presence of indomethacin (2.79 mu M) was found to have no significant effect on the responses to BK and des-Arg(9)-BK. The presence of the B-2 receptor antagonist, HOE-140 (+2.79 mu M indomethacin), resulted in a concentration-related rightward displacement of the concentration-effect curves to BK. The antagonism of the constrictor responses to BK by HOE-140 was found to be competitive (pA(2)=7.5). The responses to BK were not significantly affected by the B-1 receptor antagonist des-Arg(9)(leu(8))BK. The presence of des-Arg(9)(leu(8))BK (+2.79 mu M indomethacin) resulted in a concentration-related rightward displacement of the concentration-effect curve to des-Arg(9)-BK. The antagonism of the response to des-Arg(9)-BK by des-Arg(9)(leu(8))BK was found to be competitive (pA(2)=5.9). The responses to des-Arg(9)-BK were not significantly affected by HOE-140. The results of the present study suggest that the products of the cyclooxygenase pathway are not involved in the kinin constrictor response on HUA and indicate the presence of B-1 and B-2 receptors on this tissue.
引用
收藏
页码:389 / 394
页数:6
相关论文
共 45 条
[41]  
REGOLI D, 1980, PHARMACOL REV, V32, P1
[42]   PHARMACOLOGICAL CHARACTERIZATION OF A NEW HIGHLY POTENT B2-RECEPTOR ANTAGONIST (HOE 140-D-ARG-[HYP3,THI5,D-TIC7,OIC8]BRADYKININ) [J].
RHALEB, NE ;
ROUISSI, N ;
JUKIC, D ;
REGOLI, D ;
HENKE, S ;
BREIPOHL, G ;
KNOLLE, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (02) :115-120
[43]  
TUVEMO T, 1980, SEMIN PERINATOL, V4, P91
[44]   DESARG9-D-ARG[HYP3,THI5,D-TIC7,OIC8]BRADYKININ (DESARG10-[HOE140]) IS A POTENT BRADYKININ-B1 RECEPTOR ANTAGONIST [J].
WIRTH, K ;
BREIPOHL, G ;
STECHL, J ;
KNOLLE, J ;
HENKE, S ;
SCHOLKENS, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 205 (02) :217-218
[45]   HOE-140 A NEW POTENT AND LONG-ACTING BRADYKININ-ANTAGONIST - INVIVO STUDIES [J].
WIRTH, K ;
HOCK, FJ ;
ALBUS, U ;
LINZ, W ;
ALPERMANN, HG ;
ANAGNOSTOPOULOS, H ;
HENKE, S ;
BREIPOHL, G ;
KONIG, W ;
KNOLLE, J ;
SCHOLKENS, BA .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (03) :774-777